Antitrust

A routine tender offer extension for a small healthcare operator reveals a larger story of a struggling company, a persistent buyer, and a new regulatory era.

The Competition Bureau has moved to block Nortera's acquisition of Green Giant, arguing the deal would reduce choice and raise prices for Canadian families.

The NAIC's summer summit in Columbus places the city's robust insurance ecosystem at the center of national debates on AI governance, climate risk, and state regulation.

A seventh delay in a massive debt restructuring signals deep trouble for the Paramount-WBD mega-merger, raising questions about its financial and legal viability.

Zillow's Q2 revenue soars 18%, but a deeper look reveals a complex reality: declining user traffic, a GAAP net loss, and a high-stakes antitrust battle.

As Washington escalates its war on Big Tech, advisory firm Keystone poaches the DOJ's top economists, gaining the architects of the government's own playbook.

A Dutch court dismissed Shell’s €1B claim against Clariant, a key win. Yet, with billions more in lawsuits pending, is this a true signal of strength?

A Crown corporation's new flyer service is gutting community newspapers, sparking a crisis that pits public service against profit and threatens local democracy.

Union Pacific's merger with Norfolk Southern hinges on a deal with CN. This isn't just a corporate handshake; it's a strategic gambit that will redefine competition in the Midwest.

Millions of recent homebuyers may be eligible for a cash payment from a new $120M settlement. Here's how to claim your share and why it's just one piece of a larger antitrust battle reshaping the entire industry.

A German court ruling against genomics giant Illumina is more than a legal win for a rival; it's a shockwave hitting the core of biotech innovation and biosecurity.

Regulatory tailwinds and a user-first feature set are fueling Opera's surge in Western markets, revealing cracks in the long-held browser monopoly.

A defiant press release signals the collapse of a major defense deal. Behind the scenes, a battle over monopolies, pricing, and national security.

A Silicon Valley mobility firm is challenging a federal ruling, setting a critical precedent for public vs. private transport. Is this the end of the road for fair play?

Harvest Sherwood is dead, but its legal claims are worth a fortune. Atlas Grove's high-stakes plan isn't revival, but a billion-dollar war on an entire industry.

The AHN-Heritage Valley merger is more than a local headline. It's a calculated move in a regional healthcare war with billion-dollar stakes for competition.

A landmark study finds nearly every major AI assistant recommends its own models at high rates, except for one. The findings raise critical questions about trust, competition, and the very nature of digital influence.

A shareholder lawsuit claims Zillow misled investors about its Redfin deal, hiding an anticompetitive move that triggered a major regulatory backlash.

A Michigan ENT group's partnership with an MSO reveals a larger trend of consolidation reshaping specialty medicine, balancing physician autonomy with corporate scale.

A securities lawsuit over a $100M deal with Redfin has hammered Zillow's stock. It’s a stark lesson in the growing cost of antitrust scrutiny.